Literature DB >> 8636056

Quinine specifically inhibits the proteolipid subunit of the F0F1 H+ -ATPase of Streptococcus pneumoniae.

R Muñoz1, E García, A G De la Campa.   

Abstract

Streptococcus pneumoniae is uniquely sensitive to quinine and its derivatives, but only those alkaloids having antimalarial properties, i.e., those in the erythro configuration, also possess antipneumococcal activity. Quinine and related compounds inhibit the pneumococcal H+ -ATPase. Quinine- and optochin-resistant pneumococci showed mutations that change amino acid residues located in one of the two transmembrane alpha-helices of the c subunit of the F0F1, H+ -ATPase.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8636056      PMCID： PMC177963          DOI： 10.1128/jb.178.8.2455-2458.1996

Source DB:  PubMed          Journal:  J Bacteriol        ISSN： 0021-9193            Impact factor:   3.490


  19 in total

1.  Cellular metabolism in genetic transformation of pneumococci: requirement for protein synthesis during induction of competence.

Authors:  A Tomasz
Journal:  J Bacteriol       Date:  1970-03       Impact factor: 3.490

Review 2.  Malaria--resurgence, resistance, and research (second of two parts).

Authors:  D J Wyler
Journal:  N Engl J Med       Date:  1983-04-21       Impact factor: 91.245

Review 3.  Treatment of parasitic infections of travelers and immigrants.

Authors:  H Most
Journal:  N Engl J Med       Date:  1984-02-02       Impact factor: 91.245

4.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

5.  Effects of mitochondrial protein synthesis inhibitors on the incorporation of isoleucine into Plasmodium falciparum in vitro.

Authors:  J J Blum; A Yayon; S Friedman; H Ginsburg
Journal:  J Protozool       Date:  1984-08

6.  Quinidine in falciparum malaria.

Authors:  N J White; S Looareesuwan; D A Warrell; T Chongsuphajaisiddhi; D Bunnag; T Harinasuta
Journal:  Lancet       Date:  1981-11-14       Impact factor: 79.321

7.  Effects of mitochondrial inhibitors on intraerythrocytic Plasmodium falciparum in in vitro cultures.

Authors:  H Ginsburg; A A Divo; T G Geary; M T Boland; J B Jensen
Journal:  J Protozool       Date:  1986-02

8.  Molecular basis of the optochin-sensitive phenotype of pneumococcus: characterization of the genes encoding the F0 complex of the Streptococcus pneumoniae and Streptococcus oralis H(+)-ATPases.

Authors:  A Fenoll; R Muñoz; E García; A G de la Campa
Journal:  Mol Microbiol       Date:  1994-05       Impact factor: 3.501

9.  Studies on transformation of Escherichia coli with plasmids.

Authors:  D Hanahan
Journal:  J Mol Biol       Date:  1983-06-05       Impact factor: 5.469

10.  Intravenous quinidine for the treatment of severe falciparum malaria. Clinical and pharmacokinetic studies.

Authors:  R E Phillips; D A Warrell; N J White; S Looareesuwan; J Karbwang
Journal:  N Engl J Med       Date:  1985-05-16       Impact factor: 91.245
View more
  12 in total

1.  Viridans group streptococci are donors in horizontal transfer of topoisomerase IV genes to Streptococcus pneumoniae.

Authors:  Luz Balsalobre; María José Ferrándiz; Josefina Liñares; Fe Tubau; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

2.  Molecular characterization of disease-associated streptococci of the mitis group that are optochin susceptible.

Authors:  Luz Balsalobre; Antonia Hernández-Madrid; Daniel Llull; Antonio J Martín-Galiano; Ernesto García; Asunción Fenoll; Adela G de la Campa
Journal:  J Clin Microbiol       Date:  2006-09-13       Impact factor: 5.948

3.  Horizontal transfer of parC and gyrA in fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  M J Ferrándiz; A Fenoll; J Liñares; A G De La Campa
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

4.  Antimicrobial activities of mefloquine and a series of related compounds.

Authors:  C M Kunin; W Y Ellis
Journal:  Antimicrob Agents Chemother       Date:  2000-04       Impact factor: 5.191

5.  Mefloquine and new related compounds target the F(0) complex of the F(0)F(1) H(+)-ATPase of Streptococcus pneumoniae.

Authors:  Antonio Javier Martín-Galiano; Begoña Gorgojo; Calvin M Kunin; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 6.  Inorganic cation transport and energy transduction in Enterococcus hirae and other streptococci.

Authors:  Y Kakinuma
Journal:  Microbiol Mol Biol Rev       Date:  1998-12       Impact factor: 11.056

7.  Genetic characterization of optochin-susceptible viridans group streptococci.

Authors:  Antonio J Martín-Galiano; Luz Balsalobre; Asunción Fenoll; Adela G de la Campa
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

8.  Introduction of a carboxyl group in the first transmembrane helix of Escherichia coli F1Fo ATPase subunit c and cytoplasmic pH regulation.

Authors:  P C Jones
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

9.  Mutation in the Plasmodium falciparum CRT protein determines the stereospecific activity of antimalarial cinchona alkaloids.

Authors:  Carol E Griffin; Jonathan M Hoke; Upeka Samarakoon; Junhui Duan; Jianbing Mu; Michael T Ferdig; David C Warhurst; Roland A Cooper
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

10.  The mystery of the fourth clone: comparative genomic analysis of four non-typeable Streptococcus pneumoniae strains with different susceptibilities to optochin.

Authors:  L N Ikryannikova; D S Ischenko; G G Lominadze; A V Kanygina; I Y Karpova; E S Kostryukova; N A Mayansky; V S Skvortsov; E N Ilina; V M Govorun
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-11-12       Impact factor: 3.267
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.